Amoxicillin Capsule
Product Images NDC 67296-0002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amoxicillin (NDC 67296-0002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Images 1)

FDA Label Image

1 (Images 10)

1 (Images 10)
This is a description of Amoxicillin capsules, each containing 500 mg of amoxicillin trihydrate. The usual adult dosage is one capsule every 8 hours, as indicated in the accompanying literature. The capsules should be stored at 20° to 25°C and dispensed in a tight, light-resistant container with a child-resistant closure. These capsules are manufactured in Canada by Teva Canada Limited and distributed by Teva Pharmaceuticals in Parsippany, NJ. The product is for prescription use only.*
FDA Label Image

1 (Images 2)

1 (Images 2)
This text provides information about a medication with NDC 0093-2263-01, containing 500 mg of Amoxicillin trihydrate per tablet. It also includes instructions for dosage, storage, and manufacturing details. The medication is manufactured by Teva Canada Limited in Toronto and distributed by Teva Pharmaceuticals in Parsippany. It is recommended to keep the medication in a child-resistant container and away from children's reach.*
FDA Label Image

1 (Images 3)

1 (Images 3)
This is a description of Amoxicillin USP 875 mg tablets. The tablets are to be stored at a temperature between 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit). The dosage instructions should be followed as per the accompanying prescribing information. The product is manufactured by Teva Canada Limited in Canada and Teva Pharmaceuticals in Parsippany, NJ. The tablets should be kept out of reach of children. The NDC number for these tablets is 0093-2264-01 and the GTIN number is 00300932264014.*
FDA Label Image

1 (Images 4)

1 (Images 4)
The text provides information about a pharmaceutical product with a GTIN code of 00300934160734. The product is a powder that is equivalent to 4 grams. It contains 200 mg of amoxicillin, USP, and the dosage information is available in the accompanying prescribing information. The text also advises storing the product at 20° to 25°C (68° to 77°F) and keeping it out of reach of children. The product should be used within 14 days after reconstitution and is manufactured by Teva Pharmaceuticals.*
FDA Label Image

1 (Images 5)

1 (Images 5)
This text provides information about Amoxicillin Oral Suspension, USP, with each 5 mL containing 250 mg of Amoxicillin as the trihydrate. The NDC (National Drug Code) number for this product is 0093-4155-73, and the GTIN (Global Trade Item Number) is 0300934155730. It is advised to store this medication at 20° to 25°C (60°F to 77°F). The product needs to be reconstituted before use, with a discard after 14 days once reconstituted. This information is intended for prescription use only.*
FDA Label Image

1 (Images 6)

1 (Images 6)
This text provides information about Amoxicillin Oral Suspension, USP 400 mg per 5 mL, when reconstituted. It includes details on directions for mixing, dosage instructions, expiration date after reconstitution, and storage recommendations. The text also displays NDC and GTIN codes, along with manufacturing and branding details.*
FDA Label Image

1 (Images 7)

1 (Images 7)
The text provides information about a medication in tablet form. Each chewable tablet contains 125 mg of amoxicillin as the trihydrate. The dosage details are available in the accompanying prescribing information. The storage conditions are specified as between 20°C to 25°C (68°F to 77°F). It should be dispensed in a tight, light-resistant container as per USP guidelines, with a child-resistant closure. The text also includes details about manufacturers: Teva Canada Limited in Toronto, and Teva Pharmaceuticals in Parsippany, New Jersey.*
FDA Label Image

1 (Images 8)

1 (Images 8)
This is a description of Amoxicillin chewable tablets containing 250 mg of amoxicillin trihydrate per tablet. The tablets are indicated for use as per accompanying prescribing information. They should be stored at 20° to 25°C and dispensed in a tight, light-resistant container with a child-resistant closure. The medication is to be kept out of reach of children. Manufactured in Canada by Teva Canada Limited for Teva Pharmaceuticals in Parsippany, NJ. Each bottle contains 100 tablets. Serial numbers are found in the Serialization Coding Area.*
FDA Label Image

1 (Images 9)

1 (Images 9)
This text is a detailed description of Amoxicillin capsules manufactured by Teva Pharmaceuticals. Each capsule contains amoxicillin trihydrate equivalent to 250 mg of amoxicillin. The usual adult dosage is 1 or 2 capsules every 8 hours. The medication should be stored at 20° to 25°C (68° to 77°F) and kept in a tight, light-resistant container with a child-resistant closure. It is important to keep this and all medications out of the reach of children. The capsules are dispensed in a pack containing 500 capsules. The product is manufactured in Canada by Teva Canada Limited for Teva Pharmaceuticals located in Parsippany, NJ. The text also includes relevant identification codes such as NDC, Rx only, and GTIN. Additional information may be found in the accompanying literature.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.